Overview

With careful attention to a woman’s health, from low-dose imaging to an
innovative, interactive approach to mammography — Senographe Essential
defines patient experience.

GE Healthcare’s flagship digital mammography
system is an upgradeable platform designed to deliver clinical confidence
and give you what you need to deliver high-quality care. Senographe
Essential lets you perform a wide variety of breast procedures from in-office
or mobile screening to advanced diagnostic procedures.

Benefits

Providing expanded performance

Starting with a reliable platform upgradeable for advanced applications,
the all-in-one Senographe Essential offers remarkable flexibility.
Expert services offer the support you need for expanded performance.

Extend care with one platform

Senographe Essential is designed for screening, diagnostic and interventional
procedures. It lets you choose your upgrade path to advanced applications. Starting
with screening, the platform is upgradeable to increase its range of capabilities:
magnification, stereotaxy, SenoBright* contrast enhanced spectral mammography,
and SenoClaire* digital breast tomosynthesis3.

High throughput

With the industry’s largest field of view (24 x 31 cm), Senographe Essential also lets
you choose a standard field of view of 19 x 23 cm, allowing you to image a large
range of breast sizes.

GE Healthcare Premium View post-processing helps improve structure visibility by adjusting
brightness and contrast for almost any breast type, including implants. Because visual comfort is
very much dependent on the user’s preference, Premium View post-processing lets you choose
from four contrast strengths: PV Low, PV Medium, PV High and PVi.

An independent conversion detector with a Cesium-Iodide (CsI) scintillator on an amorphous
Silicon (a-Si) flat-panel array results in a high DQE (70%2), for efficient imaging at low dose.

With SensorySuite, you may improve your patients’ experience and enhance the high
level of patient care you provide.

Clinical Images

Advanced Applications

Stand out with privileged access to upgrades of Senographe Essential

SenoBright contrast enhanced spectral mammography

SenoBright is GE Healthcare’s first-in-class tool that combines the
quality of digital mammog-raphy with an intravenous injection of
iodine. Performed as an adjunct to inconclusive mammography
and ultrasound, SenoBright highlights areas of unusual blood
flow pat-terns that may be cause for increased suspicion - all in a
simple, quick, procedure that takes less than ten minutes - much
like a regular mammography exam.

GE Healthcare’s SenoClaire breast tomosynthesis is a 3D imaging
technology that uses a low-dose short X-ray sweep around the
compressed breast. SenoClaire provides superior sensitivity for
architectural distortions and masses, giving more clinical
confidence while delivering no more dose than a 2D standard
acquisition of the same view. SenoClaire has the potential to
replace standard 2-view mammography exams in screening.

Related

References

1. Data reported by GE detector manufacturing in July 2010. Flowers on the gantry are available in certain product configurations.
2. Measurement conditions: DQE (70% at 0 lp/mm). Mo anode track, Mo fi lter, 28kV, 8.5 mR detector entrance dose, 4.2 cm PMMA.
3. SenoClaire may not be available in all regions. It is not cleared or approved for sale by US FDA.